
Healthcare Global Enterprises (HCG) Share Price Falls 5.11% Today
Updated: 9 Oct 2026 • 9:59 am
Posted by:

Healthcare Global Enterprises Share Price moved lower in today’s trade, with HCG last traded at Rs 606.15, down 5.11% from the previous close of Rs 638.80. The company’s market capitalisation stood at Rs 9,810.65 Cr, keeping Healthcare Global Enterprises in the Mid Cap category. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes today’s Healthcare Global Enterprises Share Price move a numbers-led event rather than a news-led one. For readers tracking Healthcare Global Enterprises Share Price Today, the key question is not only the decline itself, but also how the stock’s valuation, returns and sector comparison frame the latest Healthcare Global Enterprises Stock News.
According to Univest data, the share price decline is the clearest visible signal in the session. The Healthcare Global Enterprises Share Price opened at Rs 628.35, touched a high of Rs 628.80 and a low of Rs 605.20, with the current price sitting close to the day’s low. In simple market terms, Healthcare Global Enterprises Share Price moved Rs 32.65 lower from the previous close, which makes the day’s movement easy to quantify without stretching beyond the facts. The stock’s market capitalisation remains above Rs 9,800 Cr, so this is a Mid Cap Healthcare name rather than a small trading line. For those following HCG Share Price Live, the price action is notable because the decline happened without a verified company-specific trigger in the material under review.
The opening range shows that Healthcare Global Enterprises Share Price began near the earlier reference level but drifted lower through the day. The gap between the day high and day low was Rs 23.60, while the current price of Rs 606.15 was only slightly above the low for the move. That places today’s HCG Share Price fall firmly within the intraday range rather than as an isolated spike. Healthcare Global Enterprises Share Price Today therefore reads as a clean price action event: a lower current price, a lower day change and a Mid Cap valuation base. For readers searching Healthcare Global Enterprises Share Price News, the next step is to see whether fundamentals and sector comparison support or challenge this market reaction.
Healthcare Global Enterprises (HCG) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 606.15 |
| Previous Close | Rs 638.8 |
| Today's Move | -Rs 32.65 (-5.11%) |
| Open | Rs 628.35 |
| High | Rs 628.8 |
| Low | Rs 605.2 |
| Market Capitalisation | Rs 9,810.65 crore |
| Market Cap Category | Mid Cap |
Healthcare Global Enterprises Share Price Today shows a decline of 5.11%, with the stock trading at Rs 606.15 against a previous close of Rs 638.80. The day open was Rs 628.35, the high was Rs 628.80 and the low was Rs 605.20. That means HCG Share Price spent the session below the opening level and near the lower end of its intraday band. The market capitalisation of Rs 9,810.65 Cr places the company in the Mid Cap bracket, which is useful context when reading Healthcare Global Enterprises Stock News and Healthcare Global Enterprises Share Price Update. According to Univest data, this was the latest session’s decline, not a streak move, so the focus stays on a single-day share price fall.
The price action matters because it is precise: the Healthcare Global Enterprises Share Price fall was Rs 32.65 from the prior close, and the session range was defined by Rs 628.80 at the top and Rs 605.20 at the bottom. In Healthcare Global Enterprises Share Price analysis, that combination suggests a meaningful down day in a Mid Cap Healthcare stock. For investors tracking Healthcare Global Enterprises Share Price Live, the immediate question is how such a move compares with the company’s valuation and return metrics, which makes the fundamental analysis the next useful lens.
Healthcare Global Enterprises (HCG) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 9,810.65 crore |
| P/E Ratio | 418.68x |
| P/B Ratio | 7.08x |
| ROE | 2.04% |
| ROCE | 9.77% |
| EPS | Rs 1.53 |
| Book Value Per Share | Rs 90.25 |
| Dividend Yield | 0% |
Healthcare Global Enterprises (HCG) fundamental metrics show P/E 418.68x, P/B 7.08x, ROE 2.04%, ROCE 9.77%. These figures provide context only and are not a buy or sell signal.
Healthcare Global Enterprises has a market capitalisation of Rs 9,810.65 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 418.68x, P/B at 7.08x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 2.04% and ROCE of 9.77%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 1.53, book value per share of Rs 90.25, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 43.44x, median ROE of 13.01%, median ROCE of 15.84%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 418.68x |
| Benchmark Median P/E | 43.44x |
| Benchmark Average P/E | 95.25x |
| Benchmark P/E Range | 6.79x to 1,580.52x |
| Company P/B Ratio | 7.08x |
| Benchmark Median P/B | 3.86x |
| Benchmark Average P/B | 4.39x |
| Company ROE | 2.04% |
| Benchmark Median ROE | 13.01% |
| Benchmark Average ROE | 11.76% |
| Company ROCE | 9.77% |
| Benchmark Median ROCE | 15.84% |
| Benchmark Average ROCE | 2.25% |
| Company Market Capitalisation | Rs 9,810.65 crore |
| Benchmark Median Market Cap | Rs 583.29 crore |
| Benchmark Average Market Cap | Rs 10,560.36 crore |
Healthcare Global Enterprises (HCG) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.
Healthcare Global Enterprises (HCG) has a P/E ratio of 418.68x, which is above the benchmark median of 43.44x, a difference of +863.81%. On its own, the P/E gap is a valuation reference point, not a trading call.
Healthcare Global Enterprises (HCG) has a ROE of 2.04%, which is below the benchmark median of 13.01%, a difference of -84.32%. Healthcare Global Enterprises (HCG) has a ROCE of 9.77%, which is below the benchmark median of 15.84%, a difference of -38.32%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | APOLLOHOSP | 1,13,571.91 | 52.76 | 11.38 | 23.54 | 21.73 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 91,898.83 | 100.75 | 4.93 | 12.95 | 13.93 |
| Max Healthcare Institute | MAXHEALTH | 88,191.64 | 58.54 | 7.8 | 14.53 | 14.97 |
| Aster DM Healthcare | ASTERDM | 59,286.8 | 185.29 | 13.96 | 13.07 | 16.22 |
| Fortis Healthcare | FORTIS | 58,898.06 | 55.04 | 5.68 | 11.32 | 14.07 |
Healthcare Global Enterprises (HCG) has a P/E ratio of 418.68x compared with the displayed peer median of 58.54x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 2.04% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 9.77% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Healthcare Global Enterprises (HCG) has a market capitalisation of Rs 9,810.65 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Healthcare Global Enterprises
- Healthcare Global Enterprises Share Price fell 5.11% to Rs 606.15, making today’s move clear and measurable.
- The stock traded below its opening level and near the lower end of the day’s range.
- Healthcare Global Enterprises Share Price carries a P/E of 418.68 and a P/B of 7.08.
- ROE of 2.04% and ROCE of 9.77% provide a weak-to-mixed return backdrop.
- The stock trades in the Mid Cap category with a market cap of Rs 9,810.65 Cr.
About Healthcare Global Enterprises
Healthcare Global Enterprises operates in the Healthcare sector and the Hospital & Healthcare Services industry. The company’s business is tied to healthcare services, and its market position is best understood through its listed valuation and operating ratios rather than through any broader corporate claim. Healthcare Global Enterprises Share Price therefore reflects both the company’s place in a large industry and its current financial profile. In the context of Healthcare Global Enterprises Stock News, the company stands out more for its valuation multiple and return metrics than for size alone, even though it remains a Mid Cap name in market-value terms.
Track Healthcare Global Enterprises Share Price on Univest
Use Healthcare Global Enterprises (HCG) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Univest lets readers track Healthcare Global Enterprises Share Price live along with key ratios such as P/E, P/B, ROE, ROCE, EPS, book value and dividend yield. Users can also follow the company’s 52-week levels, market capitalisation and healthcare-sector context on one place. For Healthcare Global Enterprises Share Price Today and future Healthcare Global Enterprises Stock News updates, Univest provides a clean way to monitor price action and fundamentals together.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Healthcare Global Enterprises Share Price fall today?
Ans. Healthcare Global Enterprises Share Price fell 5.11% to Rs 606.15 from Rs 638.80. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The move is therefore best read as a verified price action event.
What is Healthcare Global Enterprises Share Price today?
Ans. Healthcare Global Enterprises Share Price today was Rs 606.15, after moving down Rs 32.65 from the previous close. The stock traded between Rs 628.80 and Rs 605.20, so the session stayed within a relatively narrow intraday band.
What is the market capitalisation of Healthcare Global Enterprises?
Ans. Healthcare Global Enterprises Market Cap stood at Rs 9,810.65 Cr. That places the company in the Mid Cap category. For Healthcare Global Enterprises Share Price analysis, market capitalisation gives size context, not a quality assessment or direction call.
How is Healthcare Global Enterprises valued?
Ans. Healthcare Global Enterprises Share Price trades at a P/E of 418.68 and a P/B of 7.08. EPS is Rs 1.53 and book value is Rs 90.25. Those figures show a richer valuation than the same-industry benchmark median.
How does Healthcare Global Enterprises compare with the sector benchmark?
Ans. In the same industry, the benchmark median P/E is 43.44 and the average is 95.25. Healthcare Global Enterprises Share Price carries a much higher P/E, while its ROE of 2.04% is below the benchmark median of 13.01%.
What do ROE and ROCE show for Healthcare Global Enterprises?
Ans. Healthcare Global Enterprises Share Price is backed by ROE of 2.04% and ROCE of 9.77%. ROE shows returns on shareholder equity, while ROCE shows returns generated on capital employed. Both are useful in the valuation discussion.
What is the book value and EPS for Healthcare Global Enterprises?
Ans. EPS is Rs 1.53 and book value is Rs 90.25 per share. Those two numbers help frame Healthcare Global Enterprises Share Price against earnings power and accounting net worth, especially when combined with the current P/E and P/B ratios.
Is there a dividend yield for Healthcare Global Enterprises?
Ans. Dividend yield is 0% for Healthcare Global Enterprises Share Price. That means the current valuation discussion is not being supported by an income yield in the available figures. Investors are left with price, earnings and book-value context.
Which peers are useful for Healthcare Global Enterprises Share Price comparison?
Ans. Useful peers include Apollo Hospitals Enterprise, Max Healthcare Institute, Fortis Healthcare and Narayana Hrudayalaya They provide a clear comparison set for Healthcare Global Enterprises Share Price on P/E, P/B, ROE, ROCE and market capitalisation.
Recent Articles

Bitcoin Price Today on 12 November 2026: BTC Slips to $73,344 as Hot US Inflation, Fed Rate-Hike Bets and ETF Outflows Weigh on the Crypto Market
12 November 2026

Amicro Technology IPO Debut on 12 November 2026: Robot-Vacuum Chip Maker Touches HK$18.11 Intraday, Closes 38.2% Above Offer; Three Indian Robotics Stocks Explained
12 November 2026

Mahanadi Coalfields IPO Explained on 12 November 2026: SEBI Clears Coal India's 10% Offer for Sale Worth Up to $1 Billion, Launch Possible in Late November or Early December
12 November 2026

BofA Nifty Target Stays at 26,200 for December 2026: Hospitals and Telecom Upgraded, Two-Wheelers Turned Cautious as Nifty Trades Near 25,269 on 12 November 2026
12 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Bitcoin Price Today on 12 November 2026: BTC Slips to $73,344 as Hot US Inflation, Fed Rate-Hike Bets and ETF Outflows Weigh on the Crypto Market
Amicro Technology IPO Debut on 12 November 2026: Robot-Vacuum Chip Maker Touches HK$18.11 Intraday, Closes 38.2% Above Offer; Three Indian Robotics Stocks Explained
Mahanadi Coalfields IPO Explained on 12 November 2026: SEBI Clears Coal India's 10% Offer for Sale Worth Up to $1 Billion, Launch Possible in Late November or Early December
BofA Nifty Target Stays at 26,200 for December 2026: Hospitals and Telecom Upgraded, Two-Wheelers Turned Cautious as Nifty Trades Near 25,269 on 12 November 2026
IRFC Share Price Rises 10% in One Month to Rs 85 on 12 November 2026, but Is Still Down About 32% in 2026: Should You Buy After the Q2 FY27 Profit?
Popular this week
Rolex Rings Share Price Hits Year High of Rs 216.70, Up 118% From 52-Week Low: Q2 Profit Jumps 67% but Stock Looks Stretched

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





